Tomas Hajek1, Roger McIntyre, Martin Alda. 1. aDepartment of Psychiatry, Dalhousie University, Halifax, CanadabNational Institute of Mental Health, Klecany, Czech RepubliccDepartment of Psychiatry, University of Toronto, Toronto, Canada.
Abstract
PURPOSE OF REVIEW: Type 2 diabetes mellitus (T2DM) negatively affects brain structure and function. Meta-analytical data show that relative to age and sex matched non-psychiatric controls, patients with bipolar disorders have double the risk of T2DM. We review the evidence for association between T2DM and adverse clinical and brain imaging changes in bipolar disorders and summarize studies investigating effects of diabetes treatment on psychiatric and brain outcomes. RECENT FINDINGS: Participants with bipolar disorders and T2DM or insulin resistance demonstrate greater morbidity, chronicity and disability, and lower treatment response to Li. Bipolar disorders complicated by insulin resistance/T2DM are associated with smaller hippocampal and cortical gray matter volumes and lower prefrontal N-acetyl aspartate (neuronal marker). Treatment of T2DM yields preservation of brain gray matter and insulin sensitizers, such as pioglitazone, improve symptoms of depression in unipolar or bipolar disorders. SUMMARY: T2DM or insulin resistance frequently cooccur with bipolar disorders and are associated with negative psychiatric clinical outcomes and compromised brain health. This is clinically concerning, as patients with bipolar disorders have an increased risk of metabolic syndrome and yet often receive suboptimal medical care. At the same time treatment of T2DM and insulin resistance has positive effects on psychiatric and brain outcomes. These findings create a rich agenda for future research, which could enhance psychiatric pharmacopeia and directly impact patient care.
PURPOSE OF REVIEW: Type 2 diabetes mellitus (T2DM) negatively affects brain structure and function. Meta-analytical data show that relative to age and sex matched non-psychiatric controls, patients with bipolar disorders have double the risk of T2DM. We review the evidence for association between T2DM and adverse clinical and brain imaging changes in bipolar disorders and summarize studies investigating effects of diabetes treatment on psychiatric and brain outcomes. RECENT FINDINGS:Participants with bipolar disorders and T2DM or insulin resistance demonstrate greater morbidity, chronicity and disability, and lower treatment response to Li. Bipolar disorders complicated by insulin resistance/T2DM are associated with smaller hippocampal and cortical gray matter volumes and lower prefrontal N-acetyl aspartate (neuronal marker). Treatment of T2DM yields preservation of brain gray matter and insulin sensitizers, such as pioglitazone, improve symptoms of depression in unipolar or bipolar disorders. SUMMARY: T2DM or insulin resistance frequently cooccur with bipolar disorders and are associated with negative psychiatric clinical outcomes and compromised brain health. This is clinically concerning, as patients with bipolar disorders have an increased risk of metabolic syndrome and yet often receive suboptimal medical care. At the same time treatment of T2DM and insulin resistance has positive effects on psychiatric and brain outcomes. These findings create a rich agenda for future research, which could enhance psychiatric pharmacopeia and directly impact patient care.
Authors: Sean R McWhinney; Katharina Brosch; Vince D Calhoun; Benedicto Crespo-Facorro; Nicolas A Crossley; Udo Dannlowski; Erin Dickie; Lorielle M F Dietze; Gary Donohoe; Stefan Du Plessis; Stefan Ehrlich; Robin Emsley; Petra Furstova; David C Glahn; Alfonso Gonzalez-Valderrama; Dominik Grotegerd; Laurena Holleran; Tilo T J Kircher; Pavel Knytl; Marian Kolenic; Rebekka Lencer; Igor Nenadić; Nils Opel; Julia-Katharina Pfarr; Amanda L Rodrigue; Kelly Rootes-Murdy; Alex J Ross; Kang Sim; Antonín Škoch; Filip Spaniel; Frederike Stein; Patrik Švancer; Diana Tordesillas-Gutiérrez; Juan Undurraga; Javier Váquez-Bourgon; Aristotle Voineskos; Esther Walton; Thomas W Weickert; Cynthia Shannon Weickert; Paul M Thompson; Theo G M van Erp; Jessica A Turner; Tomas Hajek Journal: Mol Psychiatry Date: 2022-06-14 Impact factor: 13.437
Authors: Wei Shen; Qiu-Wen Wang; Yao-Nan Liu; Maria C Marchetto; Sara Linker; Si-Yao Lu; Yun Chen; Chuihong Liu; Chongye Guo; Zhikai Xing; Wei Shi; John R Kelsoe; Martin Alda; Hongwei Wang; Yi Zhong; Sen-Fang Sui; Mei Zhao; Yiming Yang; Shuangli Mi; Liping Cao; Fred H Gage; Jun Yao Journal: Proc Natl Acad Sci U S A Date: 2020-02-10 Impact factor: 11.205
Authors: Sean R McWhinney; Christoph Abé; Martin Alda; Francesco Benedetti; Erlend Bøen; Caterina Del Mar Bonnin; Tiana Borgers; Katharina Brosch; Erick J Canales-Rodríguez; Dara M Cannon; Udo Dannlowski; Ana M Díaz-Zuluaga; Torbjørn Elvsåshagen; Lisa T Eyler; Janice M Fullerton; Jose M Goikolea; Janik Goltermann; Dominik Grotegerd; Bartholomeus C M Haarman; Tim Hahn; Fleur M Howells; Martin Ingvar; Tilo T J Kircher; Axel Krug; Rayus T Kuplicki; Mikael Landén; Hannah Lemke; Benny Liberg; Carlos Lopez-Jaramillo; Ulrik F Malt; Fiona M Martyn; Elena Mazza; Colm McDonald; Genevieve McPhilemy; Sandra Meier; Susanne Meinert; Tina Meller; Elisa M T Melloni; Philip B Mitchell; Leila Nabulsi; Igor Nenadic; Nils Opel; Roel A Ophoff; Bronwyn J Overs; Julia-Katharina Pfarr; Julian A Pineda-Zapata; Edith Pomarol-Clotet; Joaquim Raduà; Jonathan Repple; Maike Richter; Kai G Ringwald; Gloria Roberts; Raymond Salvador; Jonathan Savitz; Simon Schmitt; Peter R Schofield; Kang Sim; Dan J Stein; Frederike Stein; Henk S Temmingh; Katharina Thiel; Neeltje E M van Haren; Holly Van Gestel; Cristian Vargas; Eduard Vieta; Annabel Vreeker; Lena Waltemate; Lakshmi N Yatham; Christopher R K Ching; Ole Andreassen; Paul M Thompson; Tomas Hajek Journal: Mol Psychiatry Date: 2021-04-16 Impact factor: 15.992
Authors: Christopher R K Ching; Derrek P Hibar; Tiril P Gurholt; Abraham Nunes; Sophia I Thomopoulos; Christoph Abé; Ingrid Agartz; Rachel M Brouwer; Dara M Cannon; Sonja M C de Zwarte; Lisa T Eyler; Pauline Favre; Tomas Hajek; Unn K Haukvik; Josselin Houenou; Mikael Landén; Tristram A Lett; Colm McDonald; Leila Nabulsi; Yash Patel; Melissa E Pauling; Tomas Paus; Joaquim Radua; Marcio G Soeiro-de-Souza; Giulia Tronchin; Neeltje E M van Haren; Eduard Vieta; Henrik Walter; Ling-Li Zeng; Martin Alda; Jorge Almeida; Dag Alnaes; Silvia Alonso-Lana; Cara Altimus; Michael Bauer; Bernhard T Baune; Carrie E Bearden; Marcella Bellani; Francesco Benedetti; Michael Berk; Amy C Bilderbeck; Hilary P Blumberg; Erlend Bøen; Irene Bollettini; Caterina Del Mar Bonnin; Paolo Brambilla; Erick J Canales-Rodríguez; Xavier Caseras; Orwa Dandash; Udo Dannlowski; Giuseppe Delvecchio; Ana M Díaz-Zuluaga; Danai Dima; Édouard Duchesnay; Torbjørn Elvsåshagen; Scott C Fears; Sophia Frangou; Janice M Fullerton; David C Glahn; Jose M Goikolea; Melissa J Green; Dominik Grotegerd; Oliver Gruber; Bartholomeus C M Haarman; Chantal Henry; Fleur M Howells; Victoria Ives-Deliperi; Andreas Jansen; Tilo T J Kircher; Christian Knöchel; Bernd Kramer; Beny Lafer; Carlos López-Jaramillo; Rodrigo Machado-Vieira; Bradley J MacIntosh; Elisa M T Melloni; Philip B Mitchell; Igor Nenadic; Fabiano Nery; Allison C Nugent; Viola Oertel; Roel A Ophoff; Miho Ota; Bronwyn J Overs; Daniel L Pham; Mary L Phillips; Julian A Pineda-Zapata; Sara Poletti; Mircea Polosan; Edith Pomarol-Clotet; Arnaud Pouchon; Yann Quidé; Maria M Rive; Gloria Roberts; Henricus G Ruhe; Raymond Salvador; Salvador Sarró; Theodore D Satterthwaite; Aart H Schene; Kang Sim; Jair C Soares; Michael Stäblein; Dan J Stein; Christian K Tamnes; Georgios V Thomaidis; Cristian Vargas Upegui; Dick J Veltman; Michèle Wessa; Lars T Westlye; Heather C Whalley; Daniel H Wolf; Mon-Ju Wu; Lakshmi N Yatham; Carlos A Zarate; Paul M Thompson; Ole A Andreassen Journal: Hum Brain Mapp Date: 2020-07-29 Impact factor: 5.399